tomeko

ITM2B amyloidosis

Just diagnosed with ITM2B amyloidosis?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees ITM2B amyloidosis, look for clinical trials, and connect with others living with it — all in one place.

Open the full ITM2B amyloidosis hub →

Overview

ITM2B amyloidosis is a rare condition. Also known as Familial cerebral amyloid angiopathy, ITM2B-related amyloidosis, ITM2B-related cerebral amyloid angiopathy. Tomeko brings together the specialists, research, clinical trials, treatments and community for ITM2B amyloidosis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:439254 · OMIM 117300, 176500 · ICD-10 E85.4+, I68.0* · GARD 0017741

Find care for ITM2B amyloidosis

Authoritative references for ITM2B amyloidosis

Common questions

I was just diagnosed with ITM2B amyloidosis — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees ITM2B amyloidosis, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for ITM2B amyloidosis?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat ITM2B amyloidosis, filtered to your area.

Are there clinical trials for ITM2B amyloidosis?

Tomeko shows live, recruiting studies for ITM2B amyloidosis from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com